Track Intech Biopharm's current cash ($95M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Intech Biopharm (6461.TWO) currently reports a current cash of $95M as of June 2026. That compares with $300M in the prior-year period — down 67.8% year over year. Use the charts on this page to explore Intech Biopharm's current cash history and peer comparisons.
Intech Biopharm's current cash decreased from $300M to $95M — a 67.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Intech Biopharm reported $95M in current cash as of June 2026. That compares with $300M in the prior-year period — down 67.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $95M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intech Biopharm, and consider following 6461.TWO for alerts when major investors trade the stock.
Intech Biopharm is classified in the Healthcare sector. On current cash, it currently shows $95M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6461.TWO with unrelated industries.